<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04454827</url>
  </required_header>
  <id_info>
    <org_study_id>Hypo-Fear-T1D-SI</org_study_id>
    <nct_id>NCT04454827</nct_id>
  </id_info>
  <brief_title>Fear of Hypoglycemia in Children and Adolecents With Type 1 Diabetes</brief_title>
  <official_title>Fear of Hypoglycemia in Children and Adolecents With Type 1 Diabetes and Their Parents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Ljubljana, Faculty of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Ljubljana, Faculty of Medicine</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute symptoms of hypoglycemia influence all aspects of every day life and reduce quality of&#xD;
      life of children and adolescents with type 1 diabetes and their parents. Encountering with&#xD;
      hypoglycemia can result in fobic fear of low blood glucose levels in patients with type 1&#xD;
      diabetes and their parents.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Fear of hypoglycemia is the most commonly reported problem in type 1 diabetes. By definition,&#xD;
      hypoglycemia is a state of low blood glucose that is lower than 3,6 mmol/L. It can lead to&#xD;
      uncomfortable counter-regulatory symptoms such as headaches, nervousness, weakness sweating,&#xD;
      confusion, irritability, sleepiness and dizziness. In worst cases hypoglycemia can lead to&#xD;
      loss of consciousness, seizures and death.&#xD;
&#xD;
      Unpredictability of episodes of hypoglycemia causes patients with diabetes and their family&#xD;
      members to develop symptoms of anxiety and concerns related to hypoglycemia. The acute&#xD;
      symptoms affect all fields of every day life and decrease quality of life of children and&#xD;
      adolescents with type 1 diabetes and their parents. In some individuals and their families&#xD;
      fear of hypoglycemia can lead to maintaining higher levels of blood glucose, excessive&#xD;
      glucose monitoring, sleep deprivation, stress, obsessivity in self control, dependency to&#xD;
      others etc.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2019</start_date>
  <completion_date type="Actual">September 30, 2019</completion_date>
  <primary_completion_date type="Actual">August 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Fear of Hypoglycemia</measure>
    <time_frame>5 months</time_frame>
    <description>Questionnaires</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time in ranges (below 3.9, 3.9-10, above 10 mmol/l</measure>
    <time_frame>1 year</time_frame>
    <description>If available</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HbA1c</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">316</enrollment>
  <condition>Type 1 Diabetes Mellitus</condition>
  <condition>Fear of Hypoglycemia</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Children and adolescents with type 1 diabetes and their parents&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Type 1 diabetes for more than 0.5 year&#xD;
&#xD;
          -  Age â‰¥ 1 year up to 25 years (inclusive)&#xD;
&#xD;
          -  The subject/carer is willing to follow study specific instructions&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Youth with maturity-onset diabetes of the young, hybrid, other, or missing type&#xD;
&#xD;
          -  Any significant diseases / conditions including psychiatric disorders and substance&#xD;
             abuse that in the opinion of the investigator is likely to affect the subject's&#xD;
             ability to complete the study&#xD;
&#xD;
          -  Current use of the following medications: medications that are used to lower blood&#xD;
             glucose such as Pramlintide, Metformin and GLP-1 analogs. Beta blockers,&#xD;
             glucocorticoids and other medications, which in the judgment of the investigator would&#xD;
             be a contraindication to participation in the study (Anticoagulant therapy e.g.&#xD;
             Plavix, LMW heparin, Coumadin, Immunosuppressant therapy)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>25 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>University Children's Hospital Ljubljana</name>
      <address>
        <city>Ljubljana</city>
        <state>Slovenija/Osrednja Regija</state>
        <zip>1000</zip>
        <country>Slovenia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Slovenia</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 30, 2020</study_first_submitted>
  <study_first_submitted_qc>June 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 2, 2020</study_first_posted>
  <last_update_submitted>June 30, 2020</last_update_submitted>
  <last_update_submitted_qc>June 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Type 1 Diabetes Mellitus</keyword>
  <keyword>Fear of Hypoglycemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
    <mesh_term>Hypoglycemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

